Meaterm LogoMeaterm LogoMeaterm
Stock research

Cigna Group (CI) stock

Financials·Hospital & Medical Service Plans·Market cap $74.6B
Auto-Brief · synthesised from 5 layers
CI · us_stock
NEUTRAL
Top reasons
  1. 1earnings: CI Q3 2026 earnings scheduled (scheduled 2026-11-05)
  2. 2Revenue growth 7.8% YoY, net margin 2.3%.
Generated 2026-10-13 11:19 UTC5 layers
Meaterm briefs are analytical research. Not investment advice. Not a recommendation to buy, sell, or hold any asset.

Factor grades

As of 2026-10-12
Meaterm Score
B+
58th percentile
Valuation
B-
68th percentile
Growth
C+
57th percentile
Profitability
B-
66th percentile
Momentum
C-
42nd percentile

Percentile grades within the stock’s sector, computed nightly from SEC filings. Statistical ranking, not investment advice.

Fair value estimate

Fair value estimate
—

No estimate: a peer-based figure would sit more than 60% from the market price, which says more about the peer group than about the company.

Research CI with the full toolkit
Charts, screeners, factor rankings, filings and positioning data in one browser-based terminal. Free tier, no card required.
Open CI in the Meaterm terminal →
MacroNEUTRALNo feed
0 items
  • No macro events in the recency window.
No macro events in the recency window.
CatalystsNEUTRALLive
1 item
  • earnings: CI Q3 2026 earnings scheduled (scheduled 2026-11-05)
  1. earningsScheduled 2026-11-05
    CI Q3 2026 earnings scheduled
    Consensus EPS 7.73.
    NEUTRAL
FundamentalsNEUTRALLive
1 item
  • Revenue growth 7.8% YoY, net margin 2.3%.
  • Forward P/E —, FCF $7.8B.
Revenue growth (YoY)
7.8%
>10% strong
Net margin
2.3%
>15% healthy
Debt / Equity
0.75
<1 conservative
Interest coverage
—
Beta
—
Forward P/E
—
Free cash flow
$7.8B
TTM
Earnings beat rate
—
As of 2026-06-30 · Issuer filings + market data
PositioningNEUTRALNo feed
0 items
  • Peers: 144 of 235 recently-briefed us stock names lean bullish.
As of 2026-10-13 · Meaterm
NewsNEUTRALNo feed
0 items
  • No news in the recency window.
  • Signal steady (neutral) vs the last brief.
No news in the recency window.

Key fundamentals

Revenue (TTM)
$282.4B
Net income (TTM)
$6.4B
Diluted EPS (TTM)
$24.17
Gross margin
—
Operating margin
3.5%
Net margin
2.3%

Trailing-twelve-month figures computed by Meaterm from SEC filings, refreshed nightly.

Related Hospital & Medical Service Plans stocks

UNHUNITEDHEALTH GROUP INCELVElevance Health, Inc.HUMHUMANA INCCNCCENTENE CORPMOHMOLINA HEALTHCARE, INC.

Frequently asked questions

What are the CI factor grades?

Meaterm scores Cigna Group (CI) on four factors — valuation, growth, profitability and momentum — plus an overall Meaterm Score. Each grade is a percentile ranking against the stock's sector, computed nightly from SEC-filed financial data. Grades are statistical rankings, not investment advice or a recommendation to trade.

How is the fair value estimate for CI calculated?

The estimate is the median of several peer-multiple implied values — peer P/E, EV/EBITDA, P/S and P/B applied to the company's own fundamentals — plus a sell-side consensus target when one is available. Peers come from the same industry, matched by size. When the company’s own size is not on record, or the comparable companies are too few, more than ten times larger or smaller, or disagree too much with each other or with the market price, no estimate is published and the page says why. It is a statistical reference point, not a price target and not investment advice.

Where does the data on this page come from?

Fundamentals and factor grades are computed by Meaterm from SEC filings and refreshed nightly. Positioning context comes from public CFTC and FINRA releases, and macro series from FRED. Every signal, grade and estimate shown is Meaterm’s own computation.

Is CI a good stock to invest in?

Meaterm does not answer that question. This page shows how Cigna Group (CI) ranks statistically against sector peers on valuation, growth, profitability and momentum and, where its peer group supports one, where its price sits relative to a peer-multiple estimate. Use it as research context alongside your own analysis — nothing on this page is investment advice.

How often is this page updated?

Factor grades, fundamentals and the company profile refresh nightly after each trading day. The brief layers — macro, catalysts, positioning and news — are composed when the page loads, and the fair value estimate is recomputed with recent quotes during the day.